Compounding Pharmacy Oversight Under Fire by Senate Committee

Last week, a Senate committee questioned states on the oversight of compounding pharmacies as part of its investigation into the fungal meningitis outbreak linked to products from the New England Compounding Center in Framingham, Mass., according to an AHA News Now report.

The outbreak is tied to injectable epidural steroid medication that was later recalled by NECC. The medication has caused 33 deaths and more than 480 illnesses so far, according to a Senate report.

The Senate Health, Education, Labor and Pensions Committee asked state boards of pharmacy several questions related to compounding pharmacies. The committee also asked the boards to provide their requirements for compounding pharmacies and physicians, as well as any previous complaints or disciplinary actions against NECC in their state, by Dec. 7.

More Articles on the Meningitis Outbreak:

"Bureaucratic Inertia" to Blame in NECC's Continued Operation, Senate Committee Says
House Hears Testimony on Meningitis Outbreak

CDC Launches Consultation Services for Clinicians Treating Fungal Meningitis Cases

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Patient Safety Tools & Resources Database

Top 40 Articles from the Past 6 Months